Consumer Research
EU Cannabis Imports Explained: Rules, Regulations, Safety & Quality Control
LOS ANGELES – Germany's medical Cannabis imports reached 56.9 tons ...
Former Texas Governor Rick Perry Champions Ibogaine Research at Dallas Documentary Films Event
DALLAS – Former Texas Governor Rick Perry called for broader ...
Poll Finds Broad Voter Support for Legal Hemp with Stricter Safeguards
WASHINGTON – A national survey released this week reveals that ...
Cannara Biotech Secures $10M Credit Expansion for Valleyfield Facility Growth
MONTREAL – Cannara Biotech Inc., has announced a $10 million expansion of its credit facility with Bank of Montreal (BMO) to fund enhancements at its Valleyfield, Quebec, facility. This strategic move supports the company’s ambition ...
DCC and Metrc Advance California Cannabis Safety with QR Recalls
LAKELAND – In a move aimed at strengthening public health protections in the state's regulated Cannabis sector, Metrc has introduced a new recall notification system tied to its Metrc Retail ID™ QR codes. The feature, ...
German Health Ministry Draft Sparks Patient Backlash Over Medical Cannabis Access
FRANKFURT – A recent survey by MedCanOneStop, a German medical Cannabis platform, has highlighted sharp concerns among patients about a proposed amendment from the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG) that would limit ...
Single Psilocybin Dose Shows Promise in Easing OCD Symptoms, Study Finds
LOS ANGELES – In a pioneering study, researchers from the University of Hertfordshire and Imperial College have uncovered the potential of psilocybin to alleviate symptoms of obsessive-compulsive disorder (OCD). Published in Comprehensive Psychiatry on July ...
Glass House Raid Sparks Industry Fears and Rival Tensions
LOS ANGELES – Highly Capitalized Network-HCN is closely monitoring the unfolding developments following the July 10, 2025, when federal agents from Immigration and Customs Enforcement (ICE) and the Drug Enforcement Administration (DEA) stormed Glass House ...
Cannabis Rescheduling Hits Pause as DEA Shifts Gears
WASHINGTON, D.C. – The federal cannabis rescheduling saga, already a slow-burning drama, took a sharp turn this week as Chief Administrative Law Judge John J. Mulrooney announced his retirement, effective August 1, 2025. The exit, ...
Texas Hemp Ban Showdown or Reefer Madness 2.0?
AUSTIN – The Texas Senate Committee on State Affairs ignited a fiery debate on Tuesday, July 22, 2025, during the first hearing of a special legislative session called by Governor Greg Abbott to address the ...
LEEF Brands Reports Q2 2025 Financial Results
VANCOUVER – LEEF Brands Inc. disclosed its second-quarter financials, showing steady revenue gains offset by squeezed margins and ongoing losses. The company reported $8.7 million in revenue for the period ended June 30, a 10% ...
Playing to Win: How Strategy Really Works for Cannabis Leaders
LOS ANGELES -The Cannabis industry is filled with ambitious operators, visionary founders, and well-funded enterprises. Yet despite enormous energy and investment, many companies still struggle to answer the most fundamental question in business: what is ...
MSOs Confront Billions in Uncertain Tax Liabilities
LOS ANGELES – U.S. Cannabis operators continue to navigate the constraints of IRS Section 280E, which bars deductions for standard business expenses and drives up effective tax rates. Major multi-state Cannabis operators (MSOs) have leaned ...
Tilray Medical Engages in Glioblastoma Research Through Clinical Trial in Spain
LOS ANGELES-- In a significant stride for the medical cannabis community, Tilray Medical, an affiliate of Tilray Brands, Inc., declared its involvement in a groundbreaking clinical trial slated to delve into the therapeutic potential of ...
Trulieve Cannabis Corp. Seeks $143 Million Tax Refund Amidst Dispute Over 280E Obligations
LOS ANGELES- U.S. cannabis titan, Trulieve Cannabis Corp, has lodged a claim for a $143 million tax refund from the federal government. The refund pertains to payments the firm made during the fiscal years 2019, ...
FDA Warns Against Unsupervised Use of Ketamine for Psychiatric Disorders
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has raised concerns over the unsupervised and unauthorized use of compounded ketamine and ketamine-based drugs for treating psychiatric conditions. In a recent alert, the FDA ...
Connecticut’s Cannabis Sales Soar, Surpassing $15 Million Mark for Adult-use Alone
HARTFORD, CT — Connecticut's blossoming cannabis market has reached with combined sales of adult-use and medical marijuana crossing $25 million in September 2023, according to the state's Department of Consumer Protection (DCP). This surge in ...
Colorado Cannabis Sales Surpass $15 Billion, But Recent Trends Raise Concerns
DENVER — August witnessed Colorado's recreational cannabis market and its established medical marijuana industry reach a significant landmark, achieving over $15 billion in cumulative sales since the inauguration of the adult-use market in January 2014. ...
U.S. Cannabis Banking Reform Faces New Hurdles Amid Political Drama
WASHINGTON D.C. — Recent optimism surrounding potential U.S. cannabis banking reform has encountered obstacles, with unrelated political issues clouding prospects for legislative passage. While there is hope for the U.S. Senate to pass the SAFER ...
Canada’s Cannabis Industry Faces Economic Challenges, Says Health Canada Report
OTTAWA — A recent report by the Canadian government suggests the nation's legal cannabis industry is encountering significant economic challenges, shedding light on the realities faced by businesses after the 2018 legalization. The report, titled ...
ANALYSIS: Cannabis Payments: Navigating a Landscape of Opportunities and Pitfalls
NEW YORK — Cannabis payment systems have always been rife with controversy and uncertainty. As we explore the landscape, the focus is primarily on services purporting to have a compliant mechanism to accept credit cards. ...
FSD Pharma Wins Legal Battle Against Former CEO; Ventures into Dietary Supplements
NEW YORK — In a significant legal triumph, FSD Pharma Inc. a Canadian biopharmaceutical firm, received a favorable ruling from the Ontario Superior Court of Justice on Thursday against its former chief executive, Dr. ...
Atai Life Sciences Bolsters Investment in IntelGenx Technologies
NEW YORK — Atai Life Sciences AG's (Nasdaq: ATAI) confidence in IntelGenx Technologies Corp. (OTC: IGXT) seems unwavering as its investments in the pharmaceutical firm grow. The robust belief in IntelGenx's medical technology continues to ...
New Mexico’s Cannabis Microbusiness License Fees May Rise
NEW YORK — Cannabis microbusinesses in New Mexico may soon face a hike in their annual license fees, should proposed rule changes be ratified after a public comment period. A slated policy revision by the ...
New Jersey Boosts Cannabis Industry with $12 Million in Equity Grants
LOS ANGELES — In a significant push to bolster its nascent cannabis sector, the New Jersey Economic Development Authority (NJEDA) announced a $12 million grant award to 48 marijuana enterprises as part of the state's ...
California Governor Vetoed Cannabis Cafe Bill, Citing Smoke-Free Concerns
LOS ANGELES — Governor Gavin Newsom has placed a halt on the proposed move to introduce Amsterdam-style cannabis cafes in California. Despite significant bipartisan backing, Assembly Bill 374, the bill that could have potentially transformed ...
Alaska Imposes New Restrictions on Hemp Goods Industry
LOS ANGELES— Alaska has intensified its stance on the rapidly expanding national hemp goods sector, especially targeting hemp-derived products that some locals colloquially term "diet weed." Lt. Gov. Nancy Dahlstrom inked new regulations into ...
Optimi Gains Momentum with Health Canada’s Approval for Psychedelics Supply
Toronto — Optimi, a leading Canadian psychedelics drug research and formulation enterprise, announced a pivotal achievement today. Health Canada has sanctioned an amendment to the company's Dealer's Licence, setting the stage for Optimi to commence ...
Pennsylvania Legislature Mulls Over Tax Reform Benefiting Medical Cannabis Businesses
The Pennsylvania legislature has made strides in advancing a comprehensive tax reform measure, which notably addresses a crucial obstacle faced by state-sanctioned medical cannabis entities: the IRS's 280E code. This code presently restricts these businesses ...
New York Opens Doors for Medical Cannabis Operators to Dive into Adult-Use Retail Market
NEW YORK- In a significant move on Tuesday, New York regulators gave the nod for the state's medical marijuana entities to file applications for adult-use retail licenses. This opens the arena for multi-state operators (MSOs) ...
Lucy Scientific Anticipates Sharp Losses Amidst Regulatory and Operational Costs
LOS ANGELES- Lucy Scientific Discovery Inc. has been in the spotlight, not for its recent acquisitions but for missing its annual report filing deadline with the U.S. Securities and Exchange Commission (SEC). While the company ...
Georgia Pharmacies to Offer Low-THC Cannabis Oil, Expanding Access for Medical Patients
ATLANTA- In a pioneering move, Georgia has become the first state in the U.S. to greenlight the sale of medical cannabis at independent pharmacies, with the objective of simplifying access for its registered medical cannabis ...
PharmaCielo Seeks Financial Stabilization Amid Growing Losses
LOS ANGELES- In a bid to counter increasing financial setbacks, PharmaCielo Ltd., the parent company of the Colombian cannabis cultivator PharmaCielo Colombia Holdings S.A.S., has raised $3.3 million in a recent investment round. Through the ...
Gavin Newsom’s Veto of Cannabis Cafes and Psychedelic Medicine: A Balancing Act
LOS ANGELES-California Governor Gavin Newsom's recent actions on cannabis-related bills have left both proponents of cannabis reform and the cannabis industry with mixed feelings. While he signed several bills into law that will bring significant ...
Clearmind Medicine Partners with Johns Hopkins for Psychedelic-Derived Therapeutic Trials
TEL AVIV— Clearmind Medicine Inc. a biotech firm the charge in discovering and developing innovative psychedelic-derived treatments for significant health concerns, revealed a new collaboration today. The company has forged a Clinical Trial Agreement with ...
Bank of Korea Initiates Central Bank Digital Currency Pilot Program
SEOUL — In a significant move to digitize its currency infrastructure, The Bank of Korea (BOK), in collaboration with the Financial Services Commission (FSC) and the Financial Supervisory Service (FSS), is rolling out a pilot ...
The Cannabist Company Announces Partial Redemption of Senior Secured Notes
NEW YORK – The Cannabist Company Holdings Inc a major cultivator, manufacturer, and retailer of cannabis products in the U.S., has announced its intention to partially redeem its outstanding 13% senior secured notes due by ...
California’s Psychedelic Dilemma: Governor Newsom’s Tightrope Walk on SB58
LOS ANGELES— Six decades of advocacy for psychedelic legalization in California might finally culminate with the passage of SB58, a landmark bill proposing the decriminalization of certain natural psychedelics for therapeutic use. Having cleared the ...
